Cargando…

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children

Please cite this paper as: Van Buynder et al. (2010) Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses 4(4), 171–178. Background During the first wave of A/California/7/2009(H1N1) influenza, high rates of hospitalization in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Buynder, P. G., Dhaliwal, J. K., Van Buynder, J. L., Couturier, C., Minville‐LeBlanc, M., Garceau, R., Tremblay, F.‐W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964543/ https://www.ncbi.nlm.nih.gov/pubmed/20629771 http://dx.doi.org/10.1111/j.1750-2659.2010.00146.x

Ejemplares similares

Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination
por: Van Buynder, Paul G., et al.
Publicado: (2012)

Pneumococcal vaccination in older persons: where are we today?
por: Van Buynder, Paul, et al.
Publicado: (2018)

Marketing paediatric influenza vaccination: results of a major metropolitan trial
por: Van Buynder, Paul G., et al.
Publicado: (2010)

Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–III
por: Fisher, William A., et al.
Publicado: (2022)

Parental Attitudes and Perceptions of Support after Brief Clinician Intervention Predict Intentions to Accept the Adjuvanted Seasonal Influenza Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–I
por: Fisher, William A., et al.
Publicado: (2022)

Lessons from the first year of the WAIVE study investigating the protective effect of influenza vaccine against laboratory‐confirmed influenza in hospitalised children aged 6–59 months
por: Dixon, Gabriela A, et al.
Publicado: (2010)

Clinicians Are Not Able to Infer Parental Intentions to Vaccinate Infants with a Seasonal Influenza Vaccine, and Perhaps They Should Not Try: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)–IV
por: Fisher, William A., et al.
Publicado: (2022)

Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
por: Van Buynder, Paul Gaston, et al.
Publicado: (2021)

Continuing Medical Education Improves Physician Communication Skills and Increases Likelihood of Pediatric Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)—II
por: Fisher, William A., et al.
Publicado: (2022)

Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012–2017
por: McHugh, Lisa, et al.
Publicado: (2023)

Indirect Potable Reuse: A Sustainable Water Supply Alternative
por: Rodriguez, Clemencia, et al.
Publicado: (2009)

Dioxins, Furans and PCBs in Recycled Water for Indirect Potable Reuse
por: Rodriguez, Clemencia, et al.
Publicado: (2008)

Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control
por: El Guerche-Séblain, Clotilde, et al.
Publicado: (2021)

Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
por: Baras, Benoît, et al.
Publicado: (2008)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Karlsson, Erik A., et al.
Publicado: (2016)

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020)

GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Near-Infrared Laser Adjuvant for Influenza Vaccine
por: Kashiwagi, Satoshi, et al.
Publicado: (2013)

Adjuvanted influenza vaccine dynamics
por: Parra-Rojas, César, et al.
Publicado: (2019)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
por: Nagashima, Kaito A., et al.
Publicado: (2021)

Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice
por: Haupt, Robert, et al.
Publicado: (2023)

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
por: Boikos, Constantina, et al.
Publicado: (2021)

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
por: Fochesato, Anna, et al.
Publicado: (2022)

Modelling the Economic Impact of lnfluenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
por: Nguyen, Van Hung, et al.
Publicado: (2022)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis
por: Lin, Yu-Ju, et al.
Publicado: (2018)

‘Links2HealthierBubs’ cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women
por: Sarna, Mohinder, et al.
Publicado: (2019)

Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic
por: Wood, James, et al.
Publicado: (2009)

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2022)

High‐ and low‐molecular‐weight chitosan act as adjuvants during single‐dose influenza A virus protein vaccination through distinct mechanisms
por: Lampe, Anna T., et al.
Publicado: (2020)

α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant
por: Artiaga, Bianca L., et al.
Publicado: (2016)

IL-33 Is Essential for Adjuvant Effect of Hydroxypropyl-β-Cyclodexrin on the Protective Intranasal Influenza Vaccination
por: Kobari, Shingo, et al.
Publicado: (2020)

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older
por: Pillsbury, Alexis J., et al.
Publicado: (2020)

1237. Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza
por: Buzz, Chloe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qggrluj3uku7b4ru5rj1sieais